Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part of a drive to match ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform technology for designing and ...

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending. Nasdaq Data provided by ...

The E-Gel ® electrophoresis system is ideal for routine analysis of PCR products, restriction digests, and plasmid preparations. No gels to pour, no buffer to make, no staining/destaining ...

BASEL, Switzerland - (NewMediaWire) - August 28, 2024 - Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel ("Lonza"), announced today the pricing of its dual tranche ...

Barclays analyst Charles Pitman CFA maintained a Buy rating on Lonza Group Ltd (LONN – Research Report) today and set a price target of CHF640.00. According to TipRanks, Pitman CFA is ranked ...

For example, the Lonza Group AG (VTX:LONN) share price is up 54% in the last 5 years, clearly besting the market return of around 17% (ignoring dividends). On the other hand, the more recent gains ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...